Kuan, F.-C.; Li, J.-M.; Huang, Y.-C.; Chang, S.-F.; Shi, C.-S.
Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties. Int. J. Mol. Sci. 2023, 24, 17610.
https://doi.org/10.3390/ijms242417610
AMA Style
Kuan F-C, Li J-M, Huang Y-C, Chang S-F, Shi C-S.
Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties. International Journal of Molecular Sciences. 2023; 24(24):17610.
https://doi.org/10.3390/ijms242417610
Chicago/Turabian Style
Kuan, Feng-Che, Jhy-Ming Li, Yun-Ching Huang, Shun-Fu Chang, and Chung-Sheng Shi.
2023. "Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties" International Journal of Molecular Sciences 24, no. 24: 17610.
https://doi.org/10.3390/ijms242417610
APA Style
Kuan, F.-C., Li, J.-M., Huang, Y.-C., Chang, S.-F., & Shi, C.-S.
(2023). Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties. International Journal of Molecular Sciences, 24(24), 17610.
https://doi.org/10.3390/ijms242417610